Bulletin
Investor Alert

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 4:03 p.m.

/zigman2/quotes/203509482/composite

$

369.79

Change

0.00 0.00%

Volume

Volume 33,552

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Previous close

$ 365.56

$ 369.79

Change

+4.23 +1.16%

Day low

Day high

$367.44

$376.35

Open

52 week low

52 week high

$304.01

$555.77

Open

Robert P. Ragusa

Currently, Robert P. Ragusa occupies the position of Chief Operations Officer for Illumina, Inc. and Chief Executive Officer of GRAIL, Inc. (a subsidiary of Illumina, Inc.). Mr. Ragusa is also on the board of Twist Bioscience Corp. and Dante Labs, Inc.

He previously occupied the position of Executive VP-Engineering & Global Operations at Accuray, Inc., Senior Vice President-Global Operations at Applied Biosystems, Inc. and Vice President of Applera Corp.

Robert P. Ragusa received a graduate degree from Carnegie Mellon University and an undergraduate degree and an MBA from the University of Connecticut.

Transactions

Date Shares Transaction Value
02/17/2021 3,178   Derivative/Non-derivative trans. at $494.24 per share. 1,570,695
02/17/2021 6,306   Derivative/Non-derivative trans. at $0 per share. 0
02/17/2021 694   Award at $0 per share. 0
02/09/2021 1,656   Award at $0 per share. 0
11/30/2020 50   Disposition at $319.5 per share. 15,975
11/30/2020 120   Disposition at $318.83 per share. 38,260
11/30/2020 834   Disposition at $317.44 per share. 264,745
11/30/2020 150   Disposition at $315.76 per share. 47,364
11/30/2020 580   Disposition at $314.74 per share. 182,550
11/30/2020 50   Disposition at $313.13 per share. 15,657
11/30/2020 926   Disposition at $312.35 per share. 289,237
11/30/2020 180   Disposition at $311.34 per share. 56,042
11/05/2020 1,121   Derivative/Non-derivative trans. at $311.72 per share. 349,439
08/31/2020 633   Disposition at $357.63 per share. 226,380
08/31/2020 850   Disposition at $356 per share. 302,600
08/31/2020 1,852   Disposition at $355.31 per share. 658,035
08/31/2020 1,100   Disposition at $354.09 per share. 389,499
08/31/2020 565   Disposition at $352.93 per share. 199,406
06/15/2020 300   Disposition at $344.04 per share. 103,212
06/15/2020 663   Disposition at $343.18 per share. 227,529
06/15/2020 1,155   Disposition at $341.98 per share. 394,987
06/15/2020 896   Disposition at $341.23 per share. 305,743
06/15/2020 500   Disposition at $338.74 per share. 169,370
06/15/2020 450   Disposition at $338.06 per share. 152,127
06/15/2020 461   Disposition at $336.97 per share. 155,344
06/15/2020 575   Disposition at $340 per share. 195,500
02/11/2020 6,920   Derivative/Non-derivative trans. at $296 per share. 2,048,320
02/11/2020 9,969   Derivative/Non-derivative trans. at $0 per share. 0
02/11/2020 4,985   Award at $0 per share. 0
02/05/2020 2,081   Award at $0 per share. 0
02/03/2020 1,253   Disposition at $293.1 per share. 367,255
11/05/2019 1,051   Derivative/Non-derivative trans. at $300.87 per share. 316,215
11/01/2019 1,674   Disposition at $297.28 per share. 497,647
08/08/2019 2,230   Disposition at $293.09 per share. 653,591
02/12/2019 2,222   Derivative/Non-derivative trans. at $292.2 per share. 649,269
02/12/2019 954   Award at $0 per share. 0
02/12/2019 4,540   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Robert P. Ragusa
Chief Operations Officer
Mr. Sam A. Samad
Chief Financial Officer & Senior Vice President
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Mr. Steve Phillpott
Chief Information Officer & Senior Vice President
Dr. Phillip G. Febbo
Chief Medical Officer
Dr. Joydeep Goswami
SVP-Corporate Development & Strategic Planning
Mr. Min-Jui Shen
Director-Scientific Operations & Research
Ms. Susan H. Tousi
Chief Commercial Officer
Mr. Charles E. Dadswell
Secretary, Senior VP & Compliance Officer
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathy Reeves
Chief Marketing Officer
Mr. Jose A. Torres
Chief Accounting Officer & Vice President
Ms. Juliet C. Cunningham
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.